المؤلفون: Makoto Yoshida, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Ayako Takamori, Shinichiro Hayashi, Hiroki Tashiro, Takashi Kinoshita, Hiroshi Inoue, Keisuke Kojima, Ryo Tajiri, Koichiro Takahashi, Go Kato, Tomotaka Kawayama, Masahide Tanaka, Shinya Kimura, Hiromi Kobayashi, Masaru Uchida, Hironori Sadamatsu

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Spirometry, Male, medicine.medical_specialty, medicine.drug_class, Physical activity, physical activity, Metabolic equivalent, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Bronchodilator, Internal medicine, Forced Expiratory Volume, medicine, Humans, long-acting muscarinic antagonist, In patient, 030212 general & internal medicine, Prospective Studies, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Exercise, Lung, Aged, Original Research, COPD, medicine.diagnostic_test, business.industry, Olodaterol, General Medicine, Middle Aged, medicine.disease, Benzoxazines, Bronchodilator Agents, respiratory tract diseases, Drug Combinations, Treatment Outcome, 030228 respiratory system, chemistry, Cardiology, Female, long-acting beta 2 agonist, business, Body mass index, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25992fa836e3ce7f10cca83afc16dd00Test
http://europepmc.org/articles/PMC7501469Test

المؤلفون: Colin Reisner, Klaus F. Rabe, Martin Jenkins, Brian Lipworth, Ubaldo J. Martin, Fernando J. Martinez, Samir Arora

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, bronchodilator, muscarinic antagonist, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Bronchodilator, β2- agonist, Multicenter Studies as Topic, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, education.field_of_study, COPD, integumentary system, co-suspension delivery technology, General Medicine, Middle Aged, Metered-dose inhaler, Obstructive lung disease, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Female, medicine.medical_specialty, medicine.drug_class, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Metered Dose Inhalers, education, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, lung function, Recovery of Function, medicine.disease, Glycopyrrolate, Clinical Trials, Phase III as Topic, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168165fcd6c39542bd6a0b409b60d3ecTest
https://doi.org/10.2147/copd.s229794Test

المؤلفون: Eric Bourne, Gary T. Ferguson, Yoshikazu Inoue, Kiernan DeAngelis, Hiroshi Okada, Nobuya Hayashi, Masakazu Ichinose, Osamu Hataji, Klaus F. Rabe, Shaila Ballal, Paul Dorinsky, Magnus Aurivillius, Yasushi Fukushima, Colin Reisner, Mami Takikawa

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Budesonide, Male, medicine.medical_specialty, Population, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, Severity of Illness Index, Time, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Japan, Double-Blind Method, Internal medicine, Formoterol Fumarate, medicine, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Metered Dose Inhalers, long-acting β2-agonist, education, Original Research, COPD, education.field_of_study, integumentary system, business.industry, co-suspension delivery technology, ICS/LAMA/LABA, General Medicine, Drug Tolerance, Middle Aged, medicine.disease, Metered-dose inhaler, Glycopyrrolate, Dry-powder inhaler, Bronchodilator Agents, Respiratory Function Tests, Drug Combinations, Treatment Outcome, 030228 respiratory system, Tolerability, Bronchitis, Female, Drug Monitoring, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebea17bf9328c5d1ee322ed65c26717Test
http://europepmc.org/articles/PMC6934178Test

المؤلفون: Shuchita Kaila, Mary DuCharme, Swetha R Palli, Ami R Buikema, Monica Frazer, Timothy Juday

المصدر: Journal of Comparative Effectiveness Research. 8:1299-1316

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.drug_class, Pulmonary disease, Muscarinic Antagonists, Medicare, Inverse probability of treatment weighting, Insurance Claim Review, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, medicine, Humans, 030212 general & internal medicine, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Aged, Aged, 80 and over, COPD, business.industry, β2 agonists, Health Policy, Tiotropium-olodaterol, Muscarinic antagonist, Pneumonia, Middle Aged, medicine.disease, United States, Benzoxazines, Bronchodilator Agents, Drug Combinations, Models, Economic, Treatment Outcome, 030228 respiratory system, Disease Progression, Corticosteroid, Drug Therapy, Combination, Female, Health Expenditures, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697ad907cac43d84a5f2294535f4433dTest
https://doi.org/10.2217/cer-2019-0101Test

المؤلفون: Gary T. Ferguson, Masakazu Ichinose, Hiroshi Okada, Paul Dorinsky, Yoshikazu Inoue, Nobuya Hayashi, Yasushi Fukushima, Kiernan DeAngelis, Klaus F. Rabe, Osamu Hataji, Shaila Ballal, Magnus Aurivillius, Colin Reisner, Mami Takikawa, Eric Bourne

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Budesonide, medicine.medical_specialty, Population, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Japan, Double-Blind Method, Formoterol Fumarate, Internal medicine, medicine, Clinical endpoint, long-acting muscarinic antagonist, Humans, Metered Dose Inhalers, 030212 general & internal medicine, long-acting β2-agonist, education, Original Research, COPD, education.field_of_study, integumentary system, business.industry, co-suspension delivery technology, ICS/LAMA/LABA, General Medicine, Middle Aged, medicine.disease, Glycopyrrolate, Metered-dose inhaler, Dry-powder inhaler, Confidence interval, Bronchodilator Agents, Respiratory Function Tests, Drug Combinations, Treatment Outcome, 030228 respiratory system, Female, Drug Monitoring, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919f3f71349a112e63691c0ae9430930Test
https://www.dovepress.com/efficacy-and-safety-of-budesonideglycopyrrolateformoterol-fumarate-met-peer-reviewed-article-COPDTest

المؤلفون: Syed Mohammad Tariq, Enson C Thomas

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, Time Factors, Fixed-dose combination, Review, Muscarinic Antagonists, Placebo, inhaled corticosteroid, Maintenance Chemotherapy, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, exacerbations, Maintenance therapy, Adrenal Cortex Hormones, Forced Expiratory Volume, Administration, Inhalation, medicine, COPD, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Intensive care medicine, Adverse effect, Adrenergic beta-2 Receptor Agonists, Lung, biology, business.industry, Nebulizers and Vaporizers, General Medicine, Lama, medicine.disease, biology.organism_classification, Bronchodilator Agents, Clinical trial, long-acting beta-agonist, Drug Combinations, Treatment Outcome, 030228 respiratory system, Disease Progression, Physical therapy, dual bronchodilation, business, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8d9a80a1cc15eccfe7b4ff2e707c20Test
https://doi.org/10.2147/copd.s138006Test

المؤلفون: David Price, Pablo Altman, Konstantinos Kostikas, Gustavo J Rodrigo, Dave Singh, Antonio Anzueto, Francesco Patalano, Robert Fogel, Giovanni Bader

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Time Factors, law.invention, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, Adrenal Cortex Hormones, Risk Factors, law, Forced Expiratory Volume, Bronchodilator, Odds Ratio, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, COPD, biology, LAMA, General Medicine, LABA/LAMA combinations, Lama, LABA/ICS, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Meta-analysis, Disease Progression, Corticosteroid, hormones, hormone substitutes, and hormone antagonists, medicine.drug, medicine.medical_specialty, medicine.drug_class, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Adrenergic beta-2 Receptor Agonists, Chi-Square Distribution, business.industry, Muscarinic antagonist, Recovery of Function, medicine.disease, biology.organism_classification, meta-analysis, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a515da86325caefef02d3fb52b133eTest
https://doi.org/10.2147/copd.s130482Test

المؤلفون: James F. Donohue, Anthony D'Urzo, Kenneth R. Chapman, Dave Singh

المصدر: Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 13 (2019)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Fixed-dose combination, formoterol, Review, Muscarinic Antagonists, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Aclidinium bromide, Maintenance therapy, aclidinium, Internal medicine, Formoterol Fumarate, medicine, COPD, long-acting muscarinic antagonist, Humans, Pharmacology (medical), 030212 general & internal medicine, long-acting β2-agonist, Adrenergic beta-2 Receptor Agonists, lcsh:RC705-779, biology, maintenance treatment, business.industry, lcsh:Diseases of the respiratory system, Lama, medicine.disease, biology.organism_classification, Obstructive lung disease, 3. Good health, bronchodilators, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, Quality of Life, Formoterol, business, medicine.drug, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2e6e558b3eb232ce3210aff2bd5a26Test
http://europepmc.org/articles/PMC6535700Test

المؤلفون: Guy Joos, Evelyne Vanvlasselaer, Walter Vincken, An Lehouck, Vincent Ninane, Sandra Gurdain, Paul Germonpré, Giuseppe Liistro, Wim Janssens, Jean-Louis Corhay

المساهمون: UCL - (SLuc) Service de pneumologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, Clinical sciences, Rehabilitation Research

المصدر: International Journal of Chronic Obstructive Pulmonary Disease, Vol. Volume 12, no.12, p. 793-801 (2017)
International Journal of Chronic Obstructive Pulmonary Disease
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
International journal of chronic obstructive pulmonary disease, 12

مصطلحات موضوعية: Science et gestion hospitalières, Time Factors, Delphi Technique, Delphi method, GUIDELINES, Santé publique, long acting beta agonist, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Belgium, Adrenal Cortex Hormones, Risk Factors, Forced Expiratory Volume, Medicine and Health Sciences, 030212 general & internal medicine, guidelines, Lung, Pulmonologists, Original Research, COPD, Evidence-Based Medicine, biology, General Medicine, Lama, Obstructive lung disease, Health policy, Bronchodilator Agents, REAL-LIFE, Drug Combinations, Treatment Outcome, Predictive value of tests, Disease Progression, Pneumologie, long acting muscarinic, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, PARALLEL-GROUP, Consensus, long acting muscarinic antagonist, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, CLASSIFICATION, chronic obstructive pulmonary disease, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, Administration, Inhalation, medicine, Humans, Adrenergic beta-2 Receptor Agonists, INDACATEROL, therapy, business.industry, Patient Selection, Public Health, Environmental and Occupational Health, antagonist, Evidence-based medicine, medicine.disease, biology.organism_classification, PREVENTION, Long acting muscarinic antagonist, EXACERBATIONS, 030228 respiratory system, Physical therapy, Indacaterol, inhaled corticosteroids, business, TIOTROPIUM

وصف الملف: application/pdf; Electronic-eCollection; 1 full-text file(s): application/pdf; text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eee69abe3434ab69e7af64a157dd725Test
https://hdl.handle.net/2078.1/220251Test

المؤلفون: M.K. Siddiqui, Mousumi Biswas, Mario Ouwens, Pragya Shukla, Deniz Guranlioglu, Patrick Darken, Martin Jenkins

المصدر: Therapeutic Advances in Respiratory Disease

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Agonist, medicine.drug_class, Network Meta-Analysis, Fixed-dose combination, Muscarinic Antagonists, Pharmacology, chronic obstructive pulmonary disease, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Formoterol Fumarate, Administration, Inhalation, medicine, Humans, Pharmacology (medical), Metered Dose Inhalers, 030212 general & internal medicine, long-acting muscarinic antagonist (LAMA), Adrenergic beta-2 Receptor Agonists, Glycopyrrolate, Randomized Controlled Trials as Topic, COPD, business.industry, Muscarinic antagonist, medicine.disease, Metered-dose inhaler, fixed-dose combination, Drug Combinations, 030228 respiratory system, Meta-analysis, glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI), long-acting β2-agonist (LABA), business, Meta-Analysis, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c9faf5c1c67af954183318e5d28bd0Test
https://doi.org/10.1177/1753466619894502Test